Related Experiment Video
Updated: Jul 16, 2026

Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer
1The Obstetrics and Gynecology Hospital of Medical Center of Fudan University, Shanghai, China.
Abstract:
Potassium (K(+)) channels have been implicated in proliferation of some tumor cells. However, whether K(+) channels are important to the pathogenesis of endometrial cancer (EC) remains unknown. In the present study, we report that intermediate-conductance Ca(2+)-activated K(+) (IKCa1) channels play a critical role in the development of EC. The expression of IKCa1 at both mRNA and protein levels in EC tissues was greatly increased than that in atypical hyperplasia and normal tissues. Treatment of EC cells with clotrimazole and TRAM-34, two agents known to inhibit IKCa1 channels, suppressed the proliferation of EC cells and blocked EC cell cycle at G(0)/G(1) phase. Similarly, downregulation of IKCa1 by siRNA against IKCa1 inhibited EC cell proliferation and arrested its cell cycle at G(0)/G(1) phase. A clotrimazole-sensitive K(+) current was induced in EC cells in response to the increased Ca(2+). The current density induced by Ca(2+) was greatly reduced by clotrimazole, TRAM-34, charybdotoxin or downregulation of IKCa1 by the siRNA against IKCa1. Furthermore, TRAM-34 and clotrimazole slowed the formation in nude mice of tumor generated by injection of EC cells. Our results suggest that increased activity of IKCa1 channel is necessary for the development of EC.
Insights
Intermediate-conductance calcium-activated potassium (IKCa1) channels are crucial for endometrial cancer (EC) development. Inhibiting these channels suppressed EC cell proliferation and tumor growth in mice, suggesting IKCa1 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Ion Channel Physiology
Background:
- Potassium channels influence tumor cell proliferation.
- The role of potassium channels in endometrial cancer (EC) pathogenesis is not well understood.
Purpose of the Study:
- To investigate the role of intermediate-conductance calcium-activated potassium (IKCa1) channels in endometrial cancer development.
Main Methods:
- Quantitative analysis of IKCa1 mRNA and protein expression in EC tissues versus normal and pre-cancerous tissues.
- In vitro studies using EC cell lines treated with IKCa1 inhibitors (clotrimazole, TRAM-34) or IKCa1 siRNA.
- Electrophysiological recordings to measure IKCa1 currents.
- In vivo tumor formation studies in nude mice.
Main Results:
- IKCa1 expression is significantly upregulated in EC tissues.
- IKCa1 inhibition or downregulation suppressed EC cell proliferation and induced G(0)/G(1) cell cycle arrest.
- IKCa1 specific currents were detected and inhibited by clotrimazole, TRAM-34, and charybdotoxin.
- IKCa1 inhibitors reduced tumor formation in vivo.
Conclusions:
- Increased activity of intermediate-conductance calcium-activated potassium (IKCa1) channels is essential for endometrial cancer development.
- IKCa1 represents a potential therapeutic target for endometrial cancer.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Antihypertensive Drugs: Action of Calcium Channel Blockers
Mitogens and the Cell Cycle